Clinical Trial Update: A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients with Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of GM-XANTHO (GM-XAN003) for psoriasis is described, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• GM-XANTHO

Snippet

Sponsor: Xantho Biotechnology Co., LTD | Conditions: Psoriasis | Phase 2 | Status: NOT_YET_RECRUITING